Skip to main content
Erschienen in: Annals of Surgical Oncology 12/2021

Open Access 19.04.2021 | Thoracic Oncology

Higher Dispositional Optimism Predicts Better Health-Related Quality of Life After Esophageal Cancer Surgery: A Nationwide Population-Based Longitudinal Study

verfasst von: Yangjun Liu, MD, Erik Pettersson, PhD, Anna Schandl, PhD, Sheraz Markar, PhD, Asif Johar, MSc, Pernilla Lagergren, PhD

Erschienen in: Annals of Surgical Oncology | Ausgabe 12/2021

Abstract

Purpose

To assess whether higher dispositional optimism could predict better health-related quality of life (HRQL) after esophageal cancer surgery.

Methods

This Swedish nationwide longitudinal study included 192 patients who underwent esophagectomy for cancer. The exposure was dispositional optimism measured by the Life Orientation Test-Revised (LOT-R) at 1 year post-surgery. Patients were categorized into four subgroups (very low, moderately low, moderately high, and very high dispositional optimism) based on the quartile of the LOT-R sum score. The outcome was HRQL assessed by the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire-Core 30 (QLQ-C30) and Quality of Life Questionnaire-Esophago-Gastric module 25 (QLQ-OG25) at 1, 1.5, and 2 years post-surgery. Linear mixed-effects models, adjusted for potential confounders, were used to examine the mean score difference (MSD) with 95% confidence interval of HRQL among the four patient subgroups.

Results

Patients with very high dispositional optimism reported clinically relevantly better global quality of life, emotional function, and social function (MSD range 10–16) and less severe symptoms in pain, dyspnea, diarrhea, eating difficulty, anxiety, dry mouth, trouble with taste, worry about weight loss, and self-doubt about body image (MSD range − 9 to − 22) than patients with lower dispositional optimism. Patients with moderately high dispositional optimism reported clinically and statistically significantly better global quality of life (MSD 10) and less severe diarrhea (MSD − 9) than patients with lower dispositional optimism. Adjusted MSDs were constant over the three time points in all aspects except for eating difficulty.

Conclusions

Measuring dispositional optimism could help identify patients at higher risk of poor HRQL recovery after esophageal cancer surgery.
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1245/​s10434-021-10026-w.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Esophageal cancer is a malignant tumor that ranks as the sixth leading cause of cancer death globally.1 Esophagectomy, often in combination with chemotherapy or chemoradiotherapy, is the main treatment approach with curative intent. Patients with esophagectomy for cancer usually suffer from substantially decreased health-related quality of life (HRQL), especially within 6 months post-surgery.2,3 From 1 year post-surgery, HRQL is reported to have recovered to a large extent.2,3 Previous studies have demonstrated that histology type, tumor stage, tumor location, operation approach, postoperative complications, and comorbidity are predictors of poor postoperative HRQL.47 However, patients with similar characteristics in these aspects still report varied HRQL, indicating that other factors, such as personality traits, might also have an influence.
Dispositional optimism is a relatively stable personality trait, which refers to the global expectation that more desirable than bad things will happen in the future.8 No previous study has assessed the association between dispositional optimism and HRQL among patients with esophageal cancer. Studies conducted among patients with other subtypes of cancer have shown that higher dispositional optimism is associated with better HRQL in several aspects, such as global quality of life, emotional function, social function, pain, and body image.915 However, its associations with other aspects including physical function, role function, and cognitive function were ambiguous, as some studies reported significant associations while others reported nonsignificant associations.1214,16 In addition, one study found that the association between dispositional optimism and HRQL tends to attenuate when near death.17 Given that more than 50% of surgically treated patients with esophageal cancer die within 5 years post-surgery,18 it remains uncertain whether higher dispositional optimism could predict better HRQL in this population. Clarifying this predictive effect may help identify vulnerable patients who are at higher risk of suffering from poor HRQL after surgery, thus providing early and personalized interventions to patients in need. Moreover, as dispositional optimism can be increased via psychological interventions,19 if this predictive effect exists, it may also imply a potential intervention target to improve postoperative HRQL.
In this study, we aimed to use Swedish nationwide population-based longitudinal data to assess whether higher dispositional optimism predicts better HRQL after esophageal cancer surgery.

Patients and Methods

Study Design and Data Collection

Data for this longitudinal study were drawn from a prospective, ongoing Swedish nationwide cohort study entitled Oesophageal Surgery on Cancer patients-Adaptation and Recovery (OSCAR). Detailed description of the OSCAR study has been presented elsewhere.20 In brief, it includes 1-year esophageal cancer survivors without cognitive dysfunction who underwent curative-intent esophagectomy in Sweden from 1 January 2013 onwards (response rate around 66%).20 Eligible patients are identified through collaboration with pathology departments at eight hospitals performing esophagectomy in Sweden.20 Survival information is collected through linkage to the Swedish Register of the Total Population and the Swedish cause of death register.20 Follow-ups on patient-reported outcomes start from 1 year and last until 5 years post-surgery through personal interview or mailing paper questionnaires.20 In addition, patients’ demographics are retrieved from the Swedish national health data registries and the Swedish Longitudinal Integration Database for Health Insurance and Labor Market Studies.20 Clinical data are obtained from medical charts, the Swedish Patient Registry, and the Swedish Cancer Registry.20 The study was approved by the Regional Ethical Review Board in Stockholm, Sweden (diary number 2013/844-31/1), and written consent was obtained from all participants before inclusion.
The present study included patients who underwent esophagectomy for cancer between 1 January 2013 and 28 February 2018, and incorporated three follow-up time points at 1, 1.5, and 2 years post-surgery. Patients who died during the follow-up period, had psychiatric history, or were diagnosed with noncancerous neoplasm (dysplasia) were excluded.

Exposure: Dispositional Optimism

Dispositional optimism was measured at 1 year post-surgery using the Swedish version of Life Orientation Test-Revised (LOT-R).21,22 LOT-R comprises three positively worded items and three negatively worded items,21,22 and asks patients to report their agreement with each item on a five-point Likert scale ranging from 0 (“strongly disagree”) to 4 (“strongly agree”).22
Due to the ambiguous dimensionality of LOT-R and absence of psychometric study in patients with esophageal cancer, we conducted a series of confirmatory factor analyses to assess the factor structure of LOT-R. Detailed results can be found elsewhere.23 Because the first negatively worded item had negative loading in the best-fit model and its response distribution was bimodal, we removed this item and adopted the model assuming one factor (dispositional optimism) with correlated errors between the two reversed negatively worded items. The internal reliability estimated by McDonald’s omega for this model was 0.49 [95% bootstrapped confidence interval (CI) 0.31–0.62].
The remaining five items of LOT-R were summed, of which the two negatively worded items were reversed. A higher sum score represents higher dispositional optimism. Based on the quartile of the sum score, patients were categorized into four subgroups with very low, moderately low, moderately high, and very high dispositional optimism.

Outcome: HRQL

HRQL was measured at 1, 1.5, and 2 years post-surgery using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30) and disease site-specific (Esophago-Gastric) module EORTC QLQ-OG25.24,25 Both questionnaires are validated in Swedish and have demonstrated good psychometric properties.24,25
The EORTC QLQ-C30 contains 30 items with Likert scaling and measures HRQL aspects of cancer patients in general. It consists of one global quality-of-life subscale, five functional subscales (physical, role, emotional, social, and cognitive), three symptom subscales (fatigue, pain, and nausea/vomiting), and six single items (dyspnea, appetite loss, insomnia, constipation, diarrhea, and financial difficulty).24 Items in the global quality-of-life subscale range from 1 (“very poor”) to 7 (“excellent”), while items in other subscales score from 1 (“not at all”) to 4 (“very much”).24
The EORTC QLQ-OG25 is a 25-item esophagogastric cancer-specific questionnaire, which comprises six symptom subscales (dysphagia, eating difficulty, reflux, odynophagia, pain and discomfort, and anxiety) and ten single items (eating in front of others, dry mouth, trouble with taste, trouble swallowing saliva, choked when swallowing, trouble with coughing, trouble talking, weight loss, body image, and hair loss).25 All items are scored on a four-point Likert scale ranging from 1 (“not at all”) to 4 (“very much”).25
Missing values in both questionnaires were handled according to the EORTC Scoring Manual,26 and the raw score of each HRQL subscale was transformed to a linear scale of 0–100.26 A higher score represents better function/global quality of life or higher symptom burden.26 In addition, a single summary score for the EORTC QLQ-C30 was calculated according to the EORTC guideline.27

Statistical Analysis

Sociodemographic and clinical characteristics of all included patients as well as the four patient subgroups were summarized. We compared the overall mean of the LOT-R sum score between patients with different sociodemographic and clinical characteristics using t-test or analysis of variance (ANOVA). Linear mixed-effects model was used to examine the mean score differences (MSDs) of HRQL among the four patient subgroups with hierarchical dispositional optimism levels. Covariates include time (1, 1.5, and 2 years post-surgery), age (continuous variable), sex (female or male), cohabitation status (non-cohabitating or cohabitating), education level (9-year compulsory school, upper secondary school, or higher education), Charlson Comorbidity Index28 (0 or ≥ 1), tumor stage (complete regress after neoadjuvant therapy/I, II, or III–IV), histology (squamous cell carcinoma or adenocarcinoma), postoperative Clavien–Dindo complication score (none, I–II, or III–IV), and weight change after surgery (continuous variable). Sociodemographic factors were included because they are potential confounders associated with both dispositional optimism and HRQL.29,30 Although no previous studies have suggested that clinical factors affect dispositional optimism, we included these factors as covariates to increase the estimation precision because they are strongly associated with postoperative HRQL.47,31 In addition, the interaction effect between dispositional optimism and time was examined using the Wald test. In all models, four covariance matrices (unstructured, independent, exchangeable, and identity) were compared using the Bayesian information criterion (BIC), and the one with lower BIC is preferred because it indicates better balance between goodness of fit and parsimony.32
HRQL measures several aspects; to minimize the type I error due to multiple comparisons, we tested the statistical significance of adjusted MSD only if it had clinical relevance based on evidence-based guidelines.3336 The adjusted MSD of HRQL aspects measured by EORTC QLQ-C30 has four grades: trivial (circumstances unlikely to have any clinical relevance or where there was no difference), small (subtle but clinically relevant), medium (likely to be clinically relevant but to a lesser extent), or large (of unequivocal clinical relevance).33,34 We regarded medium and large differences as clinically relevant in the present study. For other HRQL aspects, an adjusted MSD of ≥ 10 was considered clinically relevant.35,36
Stata 13 and SAS 9.4 were used for the statistical analyses. All 95% confidence intervals (CIs) were two sided.

Results

Study Participants

Figure 1 displays the detailed process of patient selection. Between 1 January 2013 and 28 February 2018, 647 patients underwent curative-intent esophageal cancer surgery in Sweden. Of these, 407 patients were invited to participate in the study, and 265 (65%) patients consented to participation and finished the first (1-year) interview. Nonparticipation was mainly due to unwillingness, poor health, and cancer recurrence.20 In addition, 73 patients were further excluded due to death during follow-up (n = 49), psychiatric history before surgery (n = 5), noncancerous histology (n = 3), and lack of essential data (n = 16), leaving 192 patients included in the analysis. Among them, 170 and 156 patients answered the 1.5- and 2-year questionnaire, respectively.

Characteristics of Participants

Table 1 presents the sociodemographic and clinical characteristics of the 192 patients. Mean age at surgery was 66.3 years [standard deviation (SD) 8.5 years, range 38.2–83.7 years). Most patients were male (85.4%) and married/cohabitating (77.1%). The mean of the LOT-R sum score was 15.2 (SD 3.0) with range of 6–20. Based on the quartile of LOT-R sum score, patients were categorized into four subgroups with hierarchical dispositional optimism levels: very low (n = 48, LOT-R sum score range 6–13), moderately low (n = 51, LOT-R sum score range 14–15), moderately high (n = 45, LOT-R sum score range 16–17), and very high (n = 48, LOT-R sum score range 19–20). Sociodemographic and clinical characteristics of the four patient subgroups are presented in Table 1. Patients with different sociodemographic and clinical characteristics reported similar LOT-sum scores (Supplementary Table S1).
Table 1
Characteristics of all included patients with esophagectomy for cancer and four patient subgroups with hierarchical dispositional optimism levels
 
All included patients (n = 192)
Dispositional optimism level
Very low (n = 48)
Moderately low (n = 51)
Moderately high (n = 45)
Very high (n = 48)
LOT-R sum score
Mean ± SD
15.2 ± 3.0
11.3 ± 1.6
14.5 ± 0.5
16.5 ± 0.5
18.9 ± 0.9
Range
[6, 20]
[6, 13]
[14, 15]
[16, 17]
[18, 20]
Age (years)
Mean ± SD
66.3 ± 8.5
64.2 ± 9.9
67.9 ± 8.3
65.7 ± 7.9
67.2 ± 7.3
Range
[38.2, 83.7]
[38.2, 82.0]
[41.5, 83.7]
[49.9, 80.5]
[50.0, 80.0]
Sex
Female
28 (14.6)
4 (8.3)
7 (13.7)
7 (15.6)
10 (20.8)
Male
164 (85.4)
44 (91.7)
44 (86.3)
38 (84.4)
38 (79.2)
Cohabitation status
Non-cohabitating
44 (22.9)
13 (27.1)
13 (25.5)
10 (22.2)
8 (16.7)
Cohabitating
148 (77.1)
35 (72.9)
38 (74.5)
35 (77.8)
40 (83.3)
Education level
Nine-year compulsory school
48 (25.0)
11 (22.9)
16 (31.4)
11 (24.4)
10 (20.8)
Upper secondary school
85 (44.3)
24 (50.0)
19 (37.3)
22 (48.9)
20 (41.7)
Higher education
59 (30.7)
13 (27.1)
16 (31.4)
12 (26.7)
18 (37.5)
Neoadjuvant therapy
Yes
158 (82.3)
41 (85.4)
38 (74.5)
37 (82.2)
42 (87.5)
No
34 (17.7)
7 (14.6)
13 (25.5)
8 (17.8)
6 (12.5)
Operation approach
Total minimally invasive esophagectomy
52 (27.1)
18 (37.5)
11 (21.6)
7 (15.6)
16 (33.3)
Hybrid minimally invasive esophagectomy
63 (32.8)
18 (37.5)
12 (23.5)
17 (37.8)
16 (33.3)
Open esophagectomy
77 (40.1)
12 (25.0)
28 (54.9)
21 (46.7)
16 (33.3)
Tumor stage
Complete regression after neoadjuvant therapy or I
71 (37.0)
15 (31.3)
27 (52.9)
12 (26.7)
17 (35.4)
II
62 (32.3)
20 (41.7)
11 (21.6)
16 (35.6)
15 (31.3)
III–IV
59 (30.7)
13 (27.1)
13 (25.5)
17 (37.8)
16 (33.3)
Tumor histology
Adenocarcinoma
163 (84.9)
43 (89.6)
39 (76.5)
43 (95.6)
38 (79.2)
Squamous cell carcinoma
29 (15.1)
5 (10.4)
12 (23.5)
2 (4.4)
10 (20.8)
Postoperative complications (Clavien–Dindo grade)
No complications
69 (35.9)
21 (43.8)
15 (29.4)
17 (37.8)
16 (33.3)
I–II
54 (28.1)
12 (25.0)
18 (35.3)
14 (31.1)
10 (20.8)
III–IV
69 (35.9)
15 (31.3)
18 (35.3)
14 (31.1)
22 (45.8)
Charlson comorbidity index
0
94 (49.0)
18 (37.5)
25 (49.0)
27 (60.0)
24 (50.0)
1
60 (31.3)
19 (39.6)
16 (31.4)
11 (24.4)
14 (29.2)
≥ 2
38 (19.8)
11 (22.9)
10 (19.6)
7 (15.6)
10 (20.8)
All values are n (%) unless otherwise stated, and the percentage is rounded up, which in some cases gives a sum not equaling to 100%
LOT-R life orientation test-revised

Time-Invariant Predictive Effect of Dispositional Optimism on HRQL

In almost all HRQL aspects except for eating difficulty, the predictive effect of dispositional optimism on HRQL was not modified by time. Over the three assessment time points, there was no clinically relevant difference between patients with very low and moderately low dispositional optimism in any HRQL aspect (Supplementary Table S2). However, compared with patients with very low and moderately low dispositional optimism, patients with moderately high dispositional optimism reported clinically relevantly and statistically significantly better global quality of life (MSD 10, 95% CI 4–17) and less severe diarrhea (MSD –9, 95% CI − 18 to − 1; Fig. 2; Supplementary Table S2). Compared with patients with very low, moderately low, and moderately high dispositional optimism, patients with very high dispositional optimism reported clinically relevantly better global quality of life, emotional function, and social function (MSD range 10–16; Fig. 3; Supplementary Table S2) and less severe symptoms of pain, dyspnea, diarrhea, anxiety, dry mouth, trouble with taste, worry about weight loss, and self-doubt about body image (MSD range − 9 to − 22; Fig. 3; Supplementary Table S2). However, the MSDs for the aspects of dry mouth and trouble with taste were marginal (MSD − 10) and not statistically significant (95% CI − 21 to 1 and − 20 to + 0, respectively; Supplementary Table S2).

Time-Varying Predictive Effect of Dispositional Optimism on HRQL

On the eating difficulty subscale, the predictive effect of dispositional optimism varied over time (interaction effect, p = 0.012). There was no clinically relevant difference between patients with moderately low and very low dispositional optimism, or between patients with moderately high and lower (very low/moderately low) dispositional optimism (Table 2). However, patients with very high dispositional optimism reported clinically relevant and statistically significant less eating difficulty than patients with lower (very low, moderately low, and moderately high) dispositional optimism, even though the MSDs varied at different time points (Table 2).
Table 2.
Mean score difference with 95% confidence interval (CI) in eating difficulty at 1, 1.5, and 2 years after esophageal cancer surgery between patients with different dispositional optimism levels
 
Time (years)
Mean score difference (95% CI)
Moderately low
Moderately high
Very high
versus very low
versus very low
versus moderately low
versus very low
versus moderately low
versus moderately high
Eating difficulty
1
8 (+0, 17)
4 (− 5, 12)
− 5 (− 13, 4)
− 4 (− 13, 4)
− 13 (− 21, − 4)
− 8 (− 16, 1)
1.5
7 (− 2, 16)
7 (− 2, 16)
0 (− 8, 9)
− 3 (− 12, 6)
− 10 (− 19, − 1)
− 10 (− 19, − 2)
2
0 (− 10, 10)
− 7 (− 18, 3)
− 7 (− 17, 3)
− 11 (− 21, − 1)
− 11 (− 21, − 1)
− 4 (− 14, 7)
Values marked in bold have both clinical and statistical significance
Mean score difference rounded up to the nearest integer

Discussion

This study showed that, compared with patients with lower dispositional optimism, patients with higher dispositional optimism reported better HRQL at 1, 1.5, and 2 years after esophageal cancer surgery, in the aspects of global quality of life, emotional function, social function, anxiety, pain, and body image, which is in line with previous studies conducted among patients with other subtypes of cancer.915 However, this study further found that dispositional optimism predicted fewer self-reported problems in dyspnea, diarrhea, dry mouth, trouble with taste, and worry about weight loss after esophageal cancer surgery.
The potential mechanisms for these observed associations might be related to coping, goal adjustment, and social support.3740 Previous studies have shown that patients with higher dispositional optimism tend to adopt more effective coping and goal adjustment strategies.3739 When the challenge is controllable, people with higher dispositional optimism tend to make every possible effort to overcome it, but if the challenge is uncontrollable, they also tend to disengage from the unattainable goals and adapt to unfavorable situations more quickly via using emotional acceptance and positive reinterpretation.37,38 Therefore, patients with higher dispositional optimism may be more persistent in pursing beneficial lifestyle,41 such as obeying the special postoperative dietary instructions, quitting smoking, and undertaking more physical exercise,41 which might help them reduce the symptoms of diarrhea and eating difficulty,42 and relieve their worry about weight loss. In addition, after esophageal cancer diagnosis and surgery, some life goals may become unattainable for patients. Timely disengagements from unrealistic goals and reengagement in new achievable goals can help patients avoid accumulating negative experience and reduce rumination,39 which might lead to better emotional function as well as less anxiety and pain.38,39 Given that psychological distress is a potential cause of dyspnea,43 better emotional function might further help optimistic patients reduce dyspnea symptom. Additionally, more optimistic people are more likely to have higher perceptions of available social support as well as actually receive higher supportiveness from significant others,40 thus leading to better social function and less self-doubt about body image. The combined beneficial effects of high dispositional optimism on the above HRQL aspects might further contribute to better global quality of life.
The observed predictive effect of dispositional optimism on HRQL among patients with esophagectomy for cancer has both clinical and research implications. It may help identify patients at higher risk of suffering from persistently impaired HRQL after esophageal cancer surgery, thus providing tailored follow-up and timely interventions to improve their postoperative HRQL. Moreover, although dispositional optimism is relatively stable, it can be increased via psychological interventions such as cognitive behavior therapy and the Best Possible Self exercise.19 The findings of this study suggest that increasing dispositional optimism might be a potential intervention target to improve postoperative HRQL. In addition, given that poor HRQL recovery is associated with higher mortality,44 the predictive value of dispositional optimism on HRQL may also imply its potential predictive effect on survival, and future studies on this topic are warranted.
To the best of the authors’ knowledge, this is the first study examining the predictive effect of dispositional optimism on HRQL after esophageal cancer surgery. The study reduced confounding bias through adjusting for several potential confounders. HRQL was measured comprehensively using both a cancer general questionnaire (EORTC QLQ-C30) and a disease-specific module (EORTC QLQ-OG25). Moreover, the clinical relevance of adjusted MSD was evaluated according to the evidence-based guidelines, and its statistical significance was tested only if it had clinical significance, which not only decreased the risk of chance findings but also ensured the clinical relevance of the results. Additionally, the nationwide population-based longitudinal study design facilitated the generalizability of the findings.
This study also has some limitations. First, because the OSCAR study focuses on patients who have survived for at least 1 year after esophagectomy, we measured dispositional optimism at 1 year post-surgery and not at time of cancer diagnosis or surgery. The observed predictive effect of dispositional optimism on HRQL should be interpreted in light of the assessment time point, even though dispositional optimism remains relatively stable over time and across stressful situations including receiving cancer diagnosis and surgery,45,46 and surgical factors were not associated with dispositional optimism based on our data. Second, we categorized patients into four subgroups according to the quartile of LOT-R sum score. Misclassification might happen due to the measurement error in the LOT-R, which can cause potential bias in either direction.47 Third, patients with lower dispositional optimism and poor HRQL might be more likely to decline to participate in the study and not answer the follow-up questionnaires, which could make the observed associations underestimated. Last but not least, prediction does not equal causation. The observed association might be due to the effect of unmeasured confounders such as genetic factors,48,49 and whether increasing dispositional optimism could improve HRQL needs to be examined by future interventional studies.
In conclusion, this study showed that higher dispositional optimism predicted better HRQL at 1, 1.5, and 2 years post-surgery in several aspects among patients with esophagectomy for cancer. The predictive value of dispositional optimism may help identify high-risk patients with poor HRQL recovery after esophageal cancer surgery, leading to timely and tailored interventions to patients in need, and therefore contribute to the improvement of postoperative HRQL and probably even survival.

Acknowledgement

We thank all patients in the OSCAR study and the patient representatives in our research partnership group for their participation. We thank our OSCAR Project team for their contribution in data collection and validation.

Disclosures

The authors declare no conflicts of interest.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

Die Chirurgie

Print-Titel

Das Abo mit mehr Tiefe

Mit der Zeitschrift Die Chirurgie erhalten Sie zusätzlich Online-Zugriff auf weitere 43 chirurgische Fachzeitschriften, CME-Fortbildungen, Webinare, Vorbereitungskursen zur Facharztprüfung und die digitale Enzyklopädie e.Medpedia.

Bis 30. April 2024 bestellen und im ersten Jahr nur 199 € zahlen!

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Anhänge

Supplementary Information

Below is the link to the electronic supplementary material.
Literatur
1.
Zurück zum Zitat Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.PubMedCrossRef Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.PubMedCrossRef
2.
Zurück zum Zitat Lagergren P, Avery KN, Hughes R, et al. Health-related quality of life among patients cured by surgery for esophageal cancer. Cancer. 2007;110(3):686–93.PubMedCrossRef Lagergren P, Avery KN, Hughes R, et al. Health-related quality of life among patients cured by surgery for esophageal cancer. Cancer. 2007;110(3):686–93.PubMedCrossRef
3.
Zurück zum Zitat Rutegard M, Lagergren J, Rouvelas I, Lindblad M, Blazeby JM, Lagergren P. Population-based study of surgical factors in relation to health-related quality of life after oesophageal cancer resection. Br J Surg. 2008;95(5):592–601.CrossRefPubMed Rutegard M, Lagergren J, Rouvelas I, Lindblad M, Blazeby JM, Lagergren P. Population-based study of surgical factors in relation to health-related quality of life after oesophageal cancer resection. Br J Surg. 2008;95(5):592–601.CrossRefPubMed
4.
Zurück zum Zitat Djarv T, Blazeby JM, Lagergren P. Predictors of postoperative quality of life after esophagectomy for cancer. J Clin Oncol. 2009;27(12):1963–8.PubMedCrossRef Djarv T, Blazeby JM, Lagergren P. Predictors of postoperative quality of life after esophagectomy for cancer. J Clin Oncol. 2009;27(12):1963–8.PubMedCrossRef
5.
Zurück zum Zitat Kauppila JH, Xie S, Johar A, Markar SR, Lagergren P. Meta-analysis of health-related quality of life after minimally invasive versus open oesophagectomy for oesophageal cancer. Br J Surg. 2017;104(9):1131–40.PubMedCrossRef Kauppila JH, Xie S, Johar A, Markar SR, Lagergren P. Meta-analysis of health-related quality of life after minimally invasive versus open oesophagectomy for oesophageal cancer. Br J Surg. 2017;104(9):1131–40.PubMedCrossRef
6.
Zurück zum Zitat Derogar M, Orsini N, Sadr-Azodi O, Lagergren P. Influence of major postoperative complications on health-related quality of life among long-term survivors of esophageal cancer surgery. J Clin Oncol. 2012;30(14):1615–9.PubMedCrossRef Derogar M, Orsini N, Sadr-Azodi O, Lagergren P. Influence of major postoperative complications on health-related quality of life among long-term survivors of esophageal cancer surgery. J Clin Oncol. 2012;30(14):1615–9.PubMedCrossRef
7.
Zurück zum Zitat Backemar L, Wikman A, Djarv T, Johar A, Lagergren P. Co-morbidity after oesophageal cancer surgery and recovery of health-related quality of life. Br J Surg. 2016;103(12):1665–75.PubMedCrossRef Backemar L, Wikman A, Djarv T, Johar A, Lagergren P. Co-morbidity after oesophageal cancer surgery and recovery of health-related quality of life. Br J Surg. 2016;103(12):1665–75.PubMedCrossRef
9.
Zurück zum Zitat de Moor JS, de Moor CA, Basen-Engquist K, Kudelka A, Bevers MW, Cohen L. Optimism, distress, health-related quality of life, and change in cancer antigen 125 among patients with ovarian cancer undergoing chemotherapy. Psychosom Med. 2006;68(4):555–62.PubMedCrossRef de Moor JS, de Moor CA, Basen-Engquist K, Kudelka A, Bevers MW, Cohen L. Optimism, distress, health-related quality of life, and change in cancer antigen 125 among patients with ovarian cancer undergoing chemotherapy. Psychosom Med. 2006;68(4):555–62.PubMedCrossRef
10.
Zurück zum Zitat Colby DA, Shifren K. Optimism, mental health, and quality of life: a study among breast cancer patients. Psychol Health Med. 2013;18(1):10–20.PubMedCrossRef Colby DA, Shifren K. Optimism, mental health, and quality of life: a study among breast cancer patients. Psychol Health Med. 2013;18(1):10–20.PubMedCrossRef
11.
Zurück zum Zitat Zenger M, Brix C, Borowski J, Stolzenburg JU, Hinz A. The impact of optimism on anxiety, depression and quality of life in urogenital cancer patients. Psycho-oncology. 2010;19(8):879–86.PubMedCrossRef Zenger M, Brix C, Borowski J, Stolzenburg JU, Hinz A. The impact of optimism on anxiety, depression and quality of life in urogenital cancer patients. Psycho-oncology. 2010;19(8):879–86.PubMedCrossRef
12.
Zurück zum Zitat Allison PJ, Guichard C, Gilain L. A prospective investigation of dispositional optimism as a predictor of health-related quality of life in head and neck cancer patients. Qual Life Res. 2000;9(8):951–60.PubMedCrossRef Allison PJ, Guichard C, Gilain L. A prospective investigation of dispositional optimism as a predictor of health-related quality of life in head and neck cancer patients. Qual Life Res. 2000;9(8):951–60.PubMedCrossRef
13.
Zurück zum Zitat Yoon H, Kim Y, Lim YO, Lee HJ, Choi K. Factors affecting quality of life of older adults with cancer in Korea. Geriatr Gerontol Int. 2015;15(8):983–90.PubMedCrossRef Yoon H, Kim Y, Lim YO, Lee HJ, Choi K. Factors affecting quality of life of older adults with cancer in Korea. Geriatr Gerontol Int. 2015;15(8):983–90.PubMedCrossRef
14.
Zurück zum Zitat Kung S, Rummans TA, Colligan RC, et al. Association of optimism-pessimism with quality of life in patients with head and neck and thyroid cancers. Mayo Clin Proc. 2006;81(12):1545–52.PubMedCrossRef Kung S, Rummans TA, Colligan RC, et al. Association of optimism-pessimism with quality of life in patients with head and neck and thyroid cancers. Mayo Clin Proc. 2006;81(12):1545–52.PubMedCrossRef
15.
Zurück zum Zitat Finck C, Barradas S, Zenger M, Hinz A. Quality of life in breast cancer patients: Associations with optimism and social support. Int J Clin Health Psychol. 2018;18(1):27–34.PubMedCrossRef Finck C, Barradas S, Zenger M, Hinz A. Quality of life in breast cancer patients: Associations with optimism and social support. Int J Clin Health Psychol. 2018;18(1):27–34.PubMedCrossRef
16.
Zurück zum Zitat Schou I, Ekeberg O, Sandvik L, Hjermstad MJ, Ruland CM. Multiple predictors of health-related quality of life in early stage breast cancer. Data from a year follow-up study compared with the general population. Qual Life Res. 2005;14(8):1813–23.PubMedCrossRef Schou I, Ekeberg O, Sandvik L, Hjermstad MJ, Ruland CM. Multiple predictors of health-related quality of life in early stage breast cancer. Data from a year follow-up study compared with the general population. Qual Life Res. 2005;14(8):1813–23.PubMedCrossRef
17.
Zurück zum Zitat Zaslavsky O, Palgi Y, Rillamas-Sun E, et al. Dispositional optimism and terminal decline in global quality of life. Dev Psychol. 2015;51(6):856–63.PubMedCrossRef Zaslavsky O, Palgi Y, Rillamas-Sun E, et al. Dispositional optimism and terminal decline in global quality of life. Dev Psychol. 2015;51(6):856–63.PubMedCrossRef
18.
Zurück zum Zitat Lagergren J, Smyth E, Cunningham D, Lagergren P. Oesophageal cancer. Lancet. 2017;390(10110):2383–96.PubMedCrossRef Lagergren J, Smyth E, Cunningham D, Lagergren P. Oesophageal cancer. Lancet. 2017;390(10110):2383–96.PubMedCrossRef
19.
Zurück zum Zitat Malouff JM, Schutte NS. Can psychological interventions increase optimism? A meta-analysis. J Posit Psychol. 2016;12(6):594–604.CrossRef Malouff JM, Schutte NS. Can psychological interventions increase optimism? A meta-analysis. J Posit Psychol. 2016;12(6):594–604.CrossRef
20.
Zurück zum Zitat Schandl A, Johar A, Anandavadivelan P, Vikstrom K, Malberg K, Lagergren P. Patient-reported outcomes 1 year after oesophageal cancer surgery. Acta Oncol. 2020;59(6):613–9.PubMedCrossRef Schandl A, Johar A, Anandavadivelan P, Vikstrom K, Malberg K, Lagergren P. Patient-reported outcomes 1 year after oesophageal cancer surgery. Acta Oncol. 2020;59(6):613–9.PubMedCrossRef
21.
Zurück zum Zitat Muhonen T, Torkelson EVA. Kortversioner av frågeformulär inom arbets-och hälsopsykologi—om att mäta coping och optimism. Nordisk Psykologi. 2005;57(3):288–97.CrossRef Muhonen T, Torkelson EVA. Kortversioner av frågeformulär inom arbets-och hälsopsykologi—om att mäta coping och optimism. Nordisk Psykologi. 2005;57(3):288–97.CrossRef
22.
Zurück zum Zitat Scheier MF, Carver CS, Bridges MW. Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): a reevaluation of the life orientation test. J Pers Soc Psychol. 1994;67(6):1063–78.CrossRefPubMed Scheier MF, Carver CS, Bridges MW. Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): a reevaluation of the life orientation test. J Pers Soc Psychol. 1994;67(6):1063–78.CrossRefPubMed
23.
Zurück zum Zitat Liu Y, Pettersson E, Johar A, Lagergren P. Confirmatory factor analysis for Life Orientation Test-Revised among patients with esophageal cancer. PsyArXiv. 2020. Liu Y, Pettersson E, Johar A, Lagergren P. Confirmatory factor analysis for Life Orientation Test-Revised among patients with esophageal cancer. PsyArXiv. 2020.
24.
Zurück zum Zitat Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–76.CrossRefPubMed Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–76.CrossRefPubMed
25.
Zurück zum Zitat Lagergren P, Fayers P, Conroy T, et al. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-OG25, to assess health-related quality of life in patients with cancer of the oesophagus, the oesophago-gastric junction and the stomach. Eur J Cancer. 2007;43(14):2066–73.PubMedCrossRef Lagergren P, Fayers P, Conroy T, et al. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-OG25, to assess health-related quality of life in patients with cancer of the oesophagus, the oesophago-gastric junction and the stomach. Eur J Cancer. 2007;43(14):2066–73.PubMedCrossRef
26.
Zurück zum Zitat Fayers P, Aaronson NK, Bjordal K, Groenvold M, Curran D, Bottomley A. EORTC QLQ-C30 scoring manual. 3rd edn. Brussels: European Organisation for Research and Treatment of Cancer; 2001. Fayers P, Aaronson NK, Bjordal K, Groenvold M, Curran D, Bottomley A. EORTC QLQ-C30 scoring manual. 3rd edn. Brussels: European Organisation for Research and Treatment of Cancer; 2001.
27.
Zurück zum Zitat Giesinger JM, Kieffer JM, Fayers PM, et al. Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ-C30 is robust. J Clin Epidemiol. 2016;69:79–88.PubMedCrossRef Giesinger JM, Kieffer JM, Fayers PM, et al. Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ-C30 is robust. J Clin Epidemiol. 2016;69:79–88.PubMedCrossRef
28.
Zurück zum Zitat Brusselaers N, Lagergren J. The Charlson comorbidity index in registry-based research. Methods Inf Med. 2017;56(5):401–6.PubMedCrossRef Brusselaers N, Lagergren J. The Charlson comorbidity index in registry-based research. Methods Inf Med. 2017;56(5):401–6.PubMedCrossRef
29.
Zurück zum Zitat Glaesmer H, Rief W, Martin A, et al. Psychometric properties and population-based norms of the life orientation test revised (LOT-R). Br J Health Psychol. 2012;17(2):432–45.PubMedCrossRef Glaesmer H, Rief W, Martin A, et al. Psychometric properties and population-based norms of the life orientation test revised (LOT-R). Br J Health Psychol. 2012;17(2):432–45.PubMedCrossRef
30.
Zurück zum Zitat Schandl AR, Johar A, Malberg K, Lagergren P. Education level and health-related quality of life after oesophageal cancer surgery: a nationwide cohort study. BMJ Open. 2018;8(8):e020702.PubMedPubMedCentralCrossRef Schandl AR, Johar A, Malberg K, Lagergren P. Education level and health-related quality of life after oesophageal cancer surgery: a nationwide cohort study. BMJ Open. 2018;8(8):e020702.PubMedPubMedCentralCrossRef
31.
Zurück zum Zitat Anandavadivelan P, Wikman A, Johar A, Lagergren P. Impact of weight loss and eating difficulties on health-related quality of life up to 10 years after oesophagectomy for cancer. Br J Surg. 2018;105(4):410–8.PubMedCrossRef Anandavadivelan P, Wikman A, Johar A, Lagergren P. Impact of weight loss and eating difficulties on health-related quality of life up to 10 years after oesophagectomy for cancer. Br J Surg. 2018;105(4):410–8.PubMedCrossRef
32.
Zurück zum Zitat Vandekerckhove J, Matzke D, Wagenmakers E-J. Model comparison and the principle of parsimony. In: The Oxford handbook of computational and mathematical psychology. New York: Oxford University Press; 2015. p. 300-19. Vandekerckhove J, Matzke D, Wagenmakers E-J. Model comparison and the principle of parsimony. In: The Oxford handbook of computational and mathematical psychology. New York: Oxford University Press; 2015. p. 300-19.
33.
Zurück zum Zitat Cocks K, King MT, Velikova G, et al. Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. Eur J Cancer. 2012;48(11):1713–21.PubMedCrossRef Cocks K, King MT, Velikova G, et al. Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. Eur J Cancer. 2012;48(11):1713–21.PubMedCrossRef
34.
Zurück zum Zitat Cocks K, King MT, Velikova G, Martyn St-James M, Fayers PM, Brown JM. Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. J Clin Oncol. 2011;29(1):89–96.PubMedCrossRef Cocks K, King MT, Velikova G, Martyn St-James M, Fayers PM, Brown JM. Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. J Clin Oncol. 2011;29(1):89–96.PubMedCrossRef
35.
Zurück zum Zitat Osoba D, Rodrigues G, Myles J, Zee B, Pater J. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol. 1998;16(1):139–44.PubMedCrossRef Osoba D, Rodrigues G, Myles J, Zee B, Pater J. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol. 1998;16(1):139–44.PubMedCrossRef
36.
Zurück zum Zitat King MT. The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Qual Life Res. 1996;5(6):555–67.PubMedCrossRef King MT. The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Qual Life Res. 1996;5(6):555–67.PubMedCrossRef
37.
Zurück zum Zitat Nes LS, Segerstrom SC. Dispositional optimism and coping: a meta-analytic review. Pers Soc Psychol Rev. 2006;10(3):235–51.PubMedCrossRef Nes LS, Segerstrom SC. Dispositional optimism and coping: a meta-analytic review. Pers Soc Psychol Rev. 2006;10(3):235–51.PubMedCrossRef
38.
Zurück zum Zitat Ramirez-Maestre C, Esteve R, Lopez-Martinez AE, Serrano-Ibanez ER, Ruiz-Parraga GT, Peters M. Goal adjustment and well-being: the role of optimism in patients with chronic pain. Ann Behav Med. 2019;53(7):597–607.PubMedCrossRef Ramirez-Maestre C, Esteve R, Lopez-Martinez AE, Serrano-Ibanez ER, Ruiz-Parraga GT, Peters M. Goal adjustment and well-being: the role of optimism in patients with chronic pain. Ann Behav Med. 2019;53(7):597–607.PubMedCrossRef
39.
Zurück zum Zitat Wrosch C, Scheier MF. Personality and quality of life: the importance of optimism and goal adjustment. Qual Life Res. 2003;12(1):59–72.PubMedCrossRef Wrosch C, Scheier MF. Personality and quality of life: the importance of optimism and goal adjustment. Qual Life Res. 2003;12(1):59–72.PubMedCrossRef
40.
Zurück zum Zitat Vollmann M, Antoniw K, Hartung F-M, Renner B. Social support as mediator of the stress buffering effect of optimism: the importance of differentiating the recipients’ and providers’ perspective. Eur J Pers. 2011;25(2):146–54.CrossRef Vollmann M, Antoniw K, Hartung F-M, Renner B. Social support as mediator of the stress buffering effect of optimism: the importance of differentiating the recipients’ and providers’ perspective. Eur J Pers. 2011;25(2):146–54.CrossRef
41.
Zurück zum Zitat Pankalainen M, Fogelholm M, Valve R, et al. Pessimism, diet, and the ability to improve dietary habits: a three-year follow-up study among middle-aged and older Finnish men and women. Nutr J. 2018;17(1):92.PubMedPubMedCentralCrossRef Pankalainen M, Fogelholm M, Valve R, et al. Pessimism, diet, and the ability to improve dietary habits: a three-year follow-up study among middle-aged and older Finnish men and women. Nutr J. 2018;17(1):92.PubMedPubMedCentralCrossRef
42.
Zurück zum Zitat Anandavadivelan P, Lagergren P. Cachexia in patients with oesophageal cancer. Nat Rev Clin Oncol. 2016;13(3):185–98.PubMedCrossRef Anandavadivelan P, Lagergren P. Cachexia in patients with oesophageal cancer. Nat Rev Clin Oncol. 2016;13(3):185–98.PubMedCrossRef
43.
Zurück zum Zitat Neuman A, Gunnbjornsdottir M, Tunsater A, et al. Dyspnea in relation to symptoms of anxiety and depression: a prospective population study. Respir Med. 2006;100(10):1843–9.PubMedCrossRef Neuman A, Gunnbjornsdottir M, Tunsater A, et al. Dyspnea in relation to symptoms of anxiety and depression: a prospective population study. Respir Med. 2006;100(10):1843–9.PubMedCrossRef
44.
Zurück zum Zitat Djarv T, Metcalfe C, Avery KN, Lagergren P, Blazeby JM. Prognostic value of changes in health-related quality of life scores during curative treatment for esophagogastric cancer. J Clin Oncol. 2010;28(10):1666–70.PubMedCrossRef Djarv T, Metcalfe C, Avery KN, Lagergren P, Blazeby JM. Prognostic value of changes in health-related quality of life scores during curative treatment for esophagogastric cancer. J Clin Oncol. 2010;28(10):1666–70.PubMedCrossRef
45.
Zurück zum Zitat Bredal IS, Ekeberg Ø. The stability of dispositional optimism in relation to receiving or not receiving a cancer diagnosis. Psychology. 2016;07(06):806–14.CrossRef Bredal IS, Ekeberg Ø. The stability of dispositional optimism in relation to receiving or not receiving a cancer diagnosis. Psychology. 2016;07(06):806–14.CrossRef
46.
Zurück zum Zitat Schou I, Ekeberg O, Sandvik L, Ruland CM. Stability in optimism-pessimism in relation to bad news: a study of women with breast cancer. J Pers Assess. 2005;84(2):148–54.PubMedCrossRef Schou I, Ekeberg O, Sandvik L, Ruland CM. Stability in optimism-pessimism in relation to bad news: a study of women with breast cancer. J Pers Assess. 2005;84(2):148–54.PubMedCrossRef
47.
Zurück zum Zitat Keogh RH, Strawbridge AD, White I. Correcting for bias due to misclassification when error-prone continuous exposures are misclassified. Epidemiol Methods. 2012;1(1):189–215. Keogh RH, Strawbridge AD, White I. Correcting for bias due to misclassification when error-prone continuous exposures are misclassified. Epidemiol Methods. 2012;1(1):189–215.
48.
Zurück zum Zitat Mosing MA, Zietsch BP, Shekar SN, Wright MJ, Martin NG. Genetic and environmental influences on optimism and its relationship to mental and self-rated health: a study of aging twins. Behav Genet. 2009;39(6):597–604.PubMedCrossRef Mosing MA, Zietsch BP, Shekar SN, Wright MJ, Martin NG. Genetic and environmental influences on optimism and its relationship to mental and self-rated health: a study of aging twins. Behav Genet. 2009;39(6):597–604.PubMedCrossRef
49.
Zurück zum Zitat Saphire-Bernstein S, Way BM, Kim HS, Sherman DK, Taylor SE. Oxytocin receptor gene (OXTR) is related to psychological resources. Proc Natl Acad Sci U S A. 2011;108(37):15118–22.PubMedPubMedCentralCrossRef Saphire-Bernstein S, Way BM, Kim HS, Sherman DK, Taylor SE. Oxytocin receptor gene (OXTR) is related to psychological resources. Proc Natl Acad Sci U S A. 2011;108(37):15118–22.PubMedPubMedCentralCrossRef
Metadaten
Titel
Higher Dispositional Optimism Predicts Better Health-Related Quality of Life After Esophageal Cancer Surgery: A Nationwide Population-Based Longitudinal Study
verfasst von
Yangjun Liu, MD
Erik Pettersson, PhD
Anna Schandl, PhD
Sheraz Markar, PhD
Asif Johar, MSc
Pernilla Lagergren, PhD
Publikationsdatum
19.04.2021
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 12/2021
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-021-10026-w

Weitere Artikel der Ausgabe 12/2021

Annals of Surgical Oncology 12/2021 Zur Ausgabe

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Deutlich weniger Infektionen: Wundprotektoren schützen!

08.05.2024 Postoperative Wundinfektion Nachrichten

Der Einsatz von Wundprotektoren bei offenen Eingriffen am unteren Gastrointestinaltrakt schützt vor Infektionen im Op.-Gebiet – und dient darüber hinaus der besseren Sicht. Das bestätigt mit großer Robustheit eine randomisierte Studie im Fachblatt JAMA Surgery.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.